AGIO

NASDAQ · Biotechnology

Agios Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$31.33

+1.92 (+6.53%)

As of Nov 9, 8:46 PM ET ·

AGIO News1 articles

Agios Pharmaceuticals Jumps on FDA Priority Review for Sickle Cell Drug

Agios Pharmaceuticals shares jumped 14.9% after the FDA accepted its mitapivat application for sickle cell disease with Priority Review, setting a Nov. 1 PDUFA date.